Keyphrases
Antimicrobial Stewardship Program
100%
Length of Stay
45%
Cost Savings
27%
Antibiotics
18%
Economic Impact
18%
Clinical Impact
18%
Australia
9%
Asia
9%
Antimicrobial
9%
Published Data
9%
Europe
9%
Africa
9%
Decision Maker
9%
Economic Outcomes
9%
North America
9%
Cost-effectiveness
9%
Inclusion Criteria
9%
MEDLINE
9%
Embase
9%
Antimicrobial Use
9%
Overall Cost
9%
Implementation Cost
9%
European Studies
9%
Judicious Use
9%
Cost Drivers
9%
Antimicrobial Resistance
9%
Economic Evaluation
9%
South America
9%
Competitive Priorities
9%
Low-middle Income Countries
9%
Mean Cost
9%
PRISMA Guidelines
9%
Hospital Size
9%
Operating Cost
9%
Antibiotic Restriction
9%
Nursing and Health Professions
Systematic Review
100%
Antimicrobial Stewardship
100%
Length of Stay
45%
Cost Control
27%
Practice Guideline
9%
Cost Effectiveness Analysis
9%
Medline
9%
Antiinfective Agent
9%
Antimicrobial Resistance
9%
Medicine and Dentistry
Antiinfective Agent
100%
Systematic Review
100%
Health Care Cost
41%
Cost-Effectiveness Analysis
8%
Antibiotic Resistance
8%
Low and Middle Income Countries
8%
Biochemistry, Genetics and Molecular Biology
Medline
100%
Antibiotic Resistance
100%
Agricultural and Biological Sciences
Systematic Review
100%
Antimicrobial Resistance
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
100%
Antimicrobial Resistance
8%